Wilmington, DE, United States of America

Michele Santer

This inventor holds 1 USPTO granted patent. Top assignee: Arkion Life Sciences, LLC. Active years: 2009.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele Santer: Innovator in Bioactive Agent Performance

Introduction

Michele Santer is a notable inventor based in Wilmington, DE (US). She has made significant contributions to the field of bioactive agents, particularly in enhancing the effectiveness of pesticide and repellent compositions. Her innovative approach has led to the development of a unique performance aid that improves the transferability of bioactive agents.

Latest Patents

Michele holds 1 patent for her invention titled "Performance aid for pesticide or repellent compositions." This patent describes a performance aid designed to increase the effectiveness of a bioactive agent. The composition adheres well to surfaces while enhancing the transferability of the bioactive agent to target animals that come into contact with the treated surfaces.

Career Highlights

Michele Santer is currently employed at Arkion Life Sciences, LLC, where she continues to innovate in the field of agricultural sciences. Her work focuses on developing solutions that improve the efficacy of bioactive agents, contributing to more effective pest control methods.

Collaborations

Michele collaborates with Kenneth E Ballinger, Jr., leveraging their combined expertise to advance research and development in their field.

Conclusion

Michele Santer's contributions to the field of bioactive agents demonstrate her commitment to innovation and effectiveness in pest management solutions. Her work at Arkion Life Sciences, LLC, and her patented invention highlight her role as a leading inventor in this important area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…